Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-11

Clinical Trial Update: Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau [Phase 1]

View source ↗

Summary

Phase 1 study examining neuronavigation-guided focused ultrasound–induced opening of the blood-brain barrier in early-onset Alzheimer's disease and its effects …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Columbia University | Conditions: Alzheimer Disease, Early Onset | Phase 1 | Status: NOT_YET_RECRUITING